Best Practices in Communicating with Healthcare Stakeholders

Effective communication of information plays a strategic role in developing relationship and trust. A clear set of rules and regulations support the quality of a system and guide healthcare communicators on how to shape their communication strategies. Healthcare stakeholders include a wide range of individuals and organizations, such as pharma industries, clinicians, advocacy groups, and policymakers.

Patients are increasingly well informed about their disease and potential treatment options. They use social media platforms to connect and discuss with other patients. An emerging group is interested in co-driving their own treatment schedule and want to become more involved in the R&D process.

Communicating with and among healthcare stakeholders, e.g. the preparation of a market launch or the information about scientific results is often shaped by risk management, which despite careful assessment can lead to unexpected crises situations, requiring professional crisis management. Last but not least the potential pitfalls, when sharing insider information, will be highlighted – an often overlooked area, where misconduct can result in harsh consequences.

This online seminar brings together a broad range of experts that come from a variety of professions who will share their insight on making decisions and communicating with and among a diverse group of healthcare stakeholders.

Join us on February 4, 2021 to reflect, learn from and discuss with the experts on this multifaceted topic.

Faculty

• Prof. Dr. Gerd Gigerenzer, Harding Center for Risk Literacy at the University of Potsdam, Faculty of Health Sciences Brandenburg, Berlin
• Dominic Elliston, Galliard Healthcare, London
• Marc C. Bauer, Agios Pharmaceuticals, Lucerne
• Dr. Gottlieb Keller, Basel
• Prof. Dr. Thomas Szucs, ECPM, Basel
• Silja Chouquet, merakoi, Basel
• Lucy Rose, Lucy Rose & Associates, Washington

About Frontiers in Drug Development Seminars

ECPM offers one day seminars on new trends and developments in drug development science. These seminars provide the opportunity to integrate work and further education, to discuss with experts face-to-face and to build an international network. They take place on the fourth day of each of the six modules of the Diploma Course and are mandatory for students taking the Diploma Course. Additionally, they are open to our alumni and other interested scientists and can be booked separately.

Learning Outcomes

Participants should learn more about various topic such as:

• Future trends in drug development including Future Information Technologies, Nano-Technologies, Computer Simulation and Modeling, Personalized Medicine, Genomics, Biologicals and Biosimilars, Advanced Therapeutics.
• Regulatory Agency updates from FDA, EMA and Swissmedic.
• Ethical, Economic and Epidemiological Considerations and Concepts in Drug Development.

Language

English

Program

One-day workshops, recognized for continuing professional development. The workshops are held on day four of each ECPM Course Module. Please find the agenda in the brochure, offered for download further below.

Credits

Six workshops over a period of two years, which equal 1 ECTS credit. Accredited as continuing education with eight credits by the Swiss Society of Pharmaceutical Medicine (SGPM) and the Swiss Society of Pharmaceutical Professionals (SwAPP). Accredited with 50 FPH-points in hospital pharmacy and 50 FPH-points in clinical pharmacy  and the Swiss Society FPH Spital (Fachgesellschaft FPH Spital).

Fee

Course fee including certificate and electronic course material is CHF 280.
A reduced fee applies to participants from academia and nonprofit organizations.

For Master of Medicines Development (MMD) participants, the fee of this module is not included in the MMD tuition fee.

Cancellation Policy

Refund of fees, less 30% administrative charges will be given if cancellations are received in written format (ecpm@unibas.ch) by Monday, January 25, 2021. After this date no refund can be given for cancella­tions. Speakers are subject to change without notice.  

Date and Venue

February 4, 2021
Online via Zoom

Deadline for Registration

January 22, 2021

Seminar Organizer

This seminar is organized by the European Center of Pharmaceutical Medicine.

Subscribe to our ECPM Newsletter to stay informed about upcoming courses and seminars.

Course Description

This online course focuses on projects in the life sciences industry and the clinical trial setting, with the aim of bringing new treatments to patients successfully.

These projects can range from early pre-clinical projects, to managing toxicology and Entry Into Human studies, large phase III clinical trials and post-marketing studies. All of them share a high complexity and require professional management at every level by experienced project managers who know the processes to reach the deliverables, can deal with multiple stakeholders simultaneously and deliver projects successfully often under a tight given budget and timelines.

This highly interactive workshop setting includes a mixture of instructor led training and group work on real life cases. All templates and tools for planning, executing, managing & controlling as well as closing a project will be developed. In addition participants have the opportunity to discuss and work on an own project, identify its challenges and develop solutions or work on a model project provided by the course instructors.

Course Program

This online course consists of two parts of four half-days each. A variety of teaching methods including lectures, exercises and interactive group discussions will be applied. A mandatory home assignment will complete the learning portfolio.

The course covers the following topics:

• Discussion of all project phases (initiation, planning, execution, monitoring & controlling, closure) and knowledge areas
• Management of scope, time, cost, quality, team, communication, risk, procurement and stakeholders
• Development of a project plan, starting from a project charter
• Creation of documents and worksheets for managing clinical trials or other projects relating to pharmaceutical development
• Discussion of Key Performance Indicators (KPIs) for project status
• Discussion of Corrective Action Preventive Action (CAPAs) to prevent the project from getting off track

Learning Outcomes

At the end of the course, participants will

• Understand the tasks and responsibilities of a project manager
• Know the major project documents required for conducting projects successfully
• Be acquainted with the tools to manage all knowledge areas throughout all project phases
• Build, lead and manage effective project teams
• Be familiar with the interactions needed with different project stakeholders
• Have a series of templates and tools at hand
• Be able to use and/or adapt these templates and tools within individual projects
• Know how to practically apply different project management standards to all kinds of pharmaceutical development projects

Course Faculty

Adam Sobanski, MAIN5 Management Consulting, Frankfurt am Main, Germany

Target Audience

Specialists responsible for projects in the pharmaceutical industry, hospital or academic setting or regulatory authority. The course not only provides the tools and fundamentals for successful project management but also illustrates real life cases. Experienced managers are encouraged to bring their current issues so that solutions can be compiled during the course.

Course Language

English

Course Credits

The course including assessment provides 4 ECTS credits.

Course Date and Venue

This course will be offered online via Zoom:

• Part 1: March 22-25, 2021 from 8:30 am to 12:30 pm
• Part 2: April 26-29, 2021 from 8:30 am to 12:30 pm

Course Fee

Course fee including certificate and electronic course material is CHF 2500.
A reduced fee applies to participants from academia and nonprofit organizations.

Cancellation Policy

Refund of fee will be given if cancellation is received in written format (ecpm@unibas.ch) before the deadline for registration, after this date no refund can be given.

Deadline for Registration

February 15, 2021

Course Organizer

This course is organized by the European Center of Pharmaceutical Medicine.

Course Description

This course intends to provide the participants with an understanding of the key principles and methodological concepts of health economics. The role of health-economic thinking in the drug development process is addressed. Two group exercises will complement lectures and discussions.

Course Program

The program includes theoretical background sessions and is enriched with exercises and in-group exercises

• Basic economic concept and principles
• Health economic evaluations principles and methods
• Health economic evaluation in drug development
• Health technology assessments and reimbursement
• Health economic evaluation alongside clinical trials and the need for modelling
• Budget impact analysis – relevance, principles, and relationship with cost-effectiveness analysis

Learning Outcomes

At the end of the course, the participants will

• Understand the fundamental concepts of health economics.
• Understand key principles of health economic evaluation.
• Be able to assess and appraise a published health economic analysis according to guidelines and checklists.
• Understand the importance of health economic/pharmacoeconomic methods and concepts for the drug development process, clinical trials, and post-marketing surveillance.
• Understand how policymakers set priorities in health care and how health economic evaluations support this process
• Understand the importance of health technology assessment in different health care systems.
• Understand rational choice and priority setting using economic evaluation.

Course Faculty

Prof. Thomas D. Szucs, MD MPH MBA LLM
Prof. Matthias Schwenkglenks, PhD MPH
Judith Lupatsch, PhD
Arjun Bhadhuri, PhD
Paola Salari, PhD

Target Audience

All pharmaceutical and health care professionals who are interested in getting a fundamental understanding of health economics and health economic evaluations in the context of drug development.

Course Language

English

Course Credits

The course including assessment provides 2 ECTS credits.

Course Date and Venue

This course will be offered online via Zoom on:
March 24-25, 2021

Course Fee

Course fee including certificate and electronic course material is CHF 1500.
A reduced fee applies to participants from academia and nonprofit organizations.

Cancellation Policy

Refund of fee will be given if cancellation is received in written format (ecpm@unibas.ch) before the deadline for registration, after this date no refund can be given.

Deadline for Registration

February 28, 2021

Course Organizer

This course is organized by the European Center of Pharmaceutical Medicine.

Course Description

Gain insights into the scientific and regulatory basis of various types of follow-on drugs: generic, biosimilar and non-biological similar medicinal products and understand their significance in the life-cycle management of medicines.

Course Language

English

Course Credits

The course including assessment provides 2 ECTS credits.

Course Fee

Course fee including certificate and electronic course material is CHF 1500.
A reduced fee applies to participants from academia and nonprofit organizations.

Cancellation Policy

Refund of fee will be given if cancellation is received in written format (ecpm@unibas.ch) before the deadline for registration, after this date no refund can be given.

Course Date and Venue

This course will be offered online via Zoom on:
April 13-14, 2021

Deadline for Registration

March 26, 2021

Course Organizer

This course is organized by the European Center of Pharmaceutical Medicine.

Course Description

Brush up your scientific and medical writing skills. Learn how to structure scientific papers and reports and write a clear and informative scientific text. This course provides a comprehensive overview of the strategic scientific and medical writing field and offers hands-on training in writing and analyzing scientific texts.

Course Program

This course will cover:

• What is the correct strategic approach to writing successful documents
• How to convey a message to the target audience
• How to produce high-quality documents
• What are the requirements to reach a successful outcome
• Ethics of scientific writing
• Practical work with multiple exercises

Learning Outcomes

By the end of the course, students will be able to:

• Know key elements of good medical and scientific writing
• Critically appraise texts and identify elements of poor writing
• Convert some examples of poor writing to good scientific writing
• Reproduce the most important aspects of good medical and scientific writing
• Improve own texts

Course Faculty

Dr. Silvia M. Rogers, MEDIWRITE, Basel, Switzerland

Target Audience

This course is for all professionals (native or non-native English speakers) who intend to improve their scientific medical writing skills.

Course Language

English

Course Credits

The course including homework provides 1 ECTS credit.
100 FPH credit points in hospital pharmacy (accreditation to be submitted)

Course Date and Venue

This course will be offered online via Zoom on two dates:

• Part 1 on April 15, 2021
• Part 2 on April 21, 2021

Course Fee

Course fee including certificate, electronic course material and the book by Silvia Rogers is CHF 800.
A reduced fee applies to participants from academia and nonprofit organizations.

Cancellation Policy

Refund of fee will be given if cancellation is received in written format (ecpm@unibas.ch) before the deadline for registration, after this date no refund can be given.

Deadline for Registration

March 31, 2021

Course Organizer

This course is organized by the European Center of Pharmaceutical Medicine.

The planned Study Trip has been postponed to 2021. Further information on the new dates will follow.

Background

After the trips to Singapore (2015, 2016), Israel (2017), Denmark (2018), and Canada (2019) the destination of the study trip 2021 is China.

Brochure

Study Trip Brochure (in German)

Program

A total of six study half-days are planned (theory and visits to institutions). The program will be available soon.

• Introduction into the health system
• Visits of hospitals
• Insurance companies
• Pharmaceutical industry

Participants

The study trip is intended for all experts working in public healthcare services. Minimum number of participants: 12 persons.

Credits

The trip provides 3 ECTS credits (rewarded after assignement has been accepted)

Study Trip Fees

Price varies according to country, registration and management via Max Künzi, 10% rebate for ECPM students. We reserve the right to change the program and/or the prices anytime.

Registration

For more information and registration please contact max.kuenzi@sagg-sahe.ch

Contact

Lic. iur. Max Künzi, MM | SAGG/SAHE | c/o Künzi Beratungen | Schachenstrasse 21 | Postfach 201 | 4702 Oensingen T (+41)(0)62 396 10 49 | F (+41)(0)62 396 24 10 | max.kuenzi@sagg-sahe.ch | www.sagg-sahe.ch | in cooperation with a travel agency.

Course Description

Brush up your scientific and medical writing skills. Learn how to structure scientific papers and reports and write a clear and informative scientific text. This course provides a comprehensive overview of the strategic scientific and medical writing field and offers hands-on training in writing and analyzing scientific texts.

Course Program

This course will cover:

• What is the correct strategic approach to writing successful documents
• How to convey a message to the target audience
• How to produce high-quality documents
• What are the requirements to reach a successful outcome
• Ethics of scientific writing
• Practical work with multiple exercises

Learning Outcomes

By the end of the course, students will be able to:

• Know key elements of good medical and scientific writing
• Critically appraise texts and identify elements of poor writing
• Convert some examples of poor writing to good scientific writing
• Reproduce the most important aspects of good medical and scientific writing
• Improve own texts

Course Faculty

Dr. Silvia M. Rogers, MEDIWRITE, Basel, Switzerland

Target Audience

This course is for all professionals (native or non-native English speakers) who intend to improve their scientific medical writing skills.

Course Language

English

Course Credits

The course including homework provides 1 ECTS credit.
100 FPH credit points in hospital pharmacy (accreditation to be submitted)

Course Date and Venue

September 27-28, 2021
University of Basel

Course Fee

Course fee including certificate, electronic course material, book by Silvia Rogers and coffee breaks is CHF 1200.
A reduced fee applies to participants from academia and nonprofit organizations.

Cancellation Policy

Refund of fee will be given if cancellation is received in written format (ecpm@unibas.ch) before the deadline for registration, after this date no refund can be given.

Deadline for Registration

August 22, 2021

Course Organizer

This course is organized by the European Center of Pharmaceutical Medicine.

Course Description

This course is an intense two-day interactive, hands-on program designed to build and expand essential presentation skills from both content and delivery perspectives. Participants will learn how to improve their personal communication skills, their ability to develop targeted, compelling and memorable presentations, and to handle difficult questions from stakeholders.

Participants should come ready to deliver a ten-minute presentation as well as a short story about a project in which they have been involved. Crucially, the story must include the type of obstacles that were faced, how they were overcome, the people or factors that helped or hindered along the way, together with the successes and failures and the outcome. Feedback from peers and the facilitators will help participants improve their ability to connect from both content and delivery perspectives.

Course Program

Day 1 – The process, establishing a baseline, stakeholders and messaging

• Introduction to developing powerful presentations
• Participants will deliver two presentations and receive direct feedback
• Stakeholder definition, prioritization and analysis
• Development of key messages

Day 2 – Storytelling, creating a narrative, and Q&A

• Storytelling techniques
• Structure and storyboard a presentation to address key stakeholders
• Media techniques to confidently handle question and answer sessions
• Delivery of final presentations by participants

Learning Outcomes

By the end of the course, participants will have a better understanding of how to:

• Present in a more compelling way to internal and external stakeholders with increased confidence and capability
• Use skills and techniques to:
  • Translate complex concepts into scalable and tailored messages for stakeholders
  • Develop engaging narratives using storytelling models that showcase and differentiate their science/project
  • Speak effectively to groups of any size face-to-face and online
  • Confidently handle question and answer sessions

Course Faculty

O’Patrick Wilson and Jennifer Sgueglia, O public relations GmbH, Ettingen, Switzerland

Target Audience

The course is designed for participants who want to improve their personal communication skills, their ability to develop targeted, compelling and memorable presentations, and to handle difficult questions from stakeholders.

Course Language

English

Course Credits

The course including assessment provides 2 ECTS credits.

Course Date and Venue

October 26-27, 2021
University of Basel

Course Fee

Course fee including certificate, electronic course material and coffee breaks is CHF 1800.
A reduced fee applies to participants from academia and nonprofit organizations.

Cancellation Policy

Refund of fee will be given if cancellation is received in written format (ecpm@unibas.ch) before the deadline for registration, after this date no refund can be given.

Deadline for Registration

October 11, 2021

Course Organizer

This course is organized by the European Center of Pharmaceutical Medicine.

Kursbeschreibung

Die rasanten Fortschritte der molekularen Medizin beeinflussen immer mehr klinische Disziplinen und zwingen die Leistungserbringer, sich vermehrt mit diesen Themen auseinanderzusetzen. Auch Patientinnen und Patienten konfrontieren die Ärzte- und Apothekerschaft zunehmend mit Fragen zu genetischen Tests. Letztendlich wollen auch sie erfahren, welchen Einfluss die molekulare Medizin auf den klinischen  Entscheidungsprozess hat.

Im Zertifikatskurs «Klinisch-genomische Medizin: Genetic Counseling» werden in komprimierter Art und Weise die wichtigsten Grundlagen der genomischen und personalisierten Medizin durch ausgewiesene Experten vermittelt. Die Teilnehmenden lernen, die Erkenntnisse molekularer Möglichkeiten klinisch einzuordnen und erfahren Wissenswertes über die zukünftigen und aussichtsreichsten  Anwendungsgebiete dieser faszinierenden Technologien.

Modul A: Grundlagen der genomischen Medizin
Modul B: Klinische Anwendungen der genomischen Medizin
Modul C: Personalisierte Medizin und Public Health Genomics

Weitere Informationen

Leitung und Organisation
Kursdetails und Teilnahmegebühren
Lehrveranstaltungsplan

Termine

• Lehrveranstaltungsblock A1: Freitag-Samstag, 29.-30.Mai 2020 Unterrichtzeit: 8.30 –17.30 Uhr
• Lehrveranstaltungsblock A2: Donnerstag –Samstag, 25.-27. Juni 2020 Unterrichtzeit: 8.30 –17.30 Uhr
• Lehrveranstaltungsblock B1: Freitag, 21. August 2020 Unterrichtzeit: 8.30 –17.30 Uhr
• Lehrveranstaltungsblock B2: Donnerstag–Samstag, 24.-26. September 2020 Unterrichtzeit: 8.30 –17.30 Uhr
• Lehrveranstaltungsblock C1: Donnerstag–Samstag,15.-17.Oktober 2020 Unterrichtzeit: 8.30 –17.30 Uhr
• Lehrveranstaltungsblock C2: Donnerstag–Samstag,19.-21. November 2020 Unterrichtzeit: 8.30 –17.30 Uhr
• Lehrveranstaltungsblock B3: Donnerstag–Samstag, 03.-05. Dezember 2020 Unterrichtzeit: 8.30 –17.30 Uhr

Kontakt

Private Universität im Fürstentum Lichtenstein
Margot Hermann
studium@ufl.li
+423 392 40 10

Course Description

Successful clinical research requires clinical experience, but also extensive knowledge about all phases of the clinical research process, awareness of regulatory requirements as well as project management and leadership skills. The complex and highly competitive nature of clinical research, results in a growing need for well-trained clinical research professionals, not least those working as study coordinators, study managers, clinical monitors or clinical research assistants.

Clinical research professionals usually start their careers with background knowledge from diverse graduate training often lacking structured training in clinical research. Still, they are facing highly demanding responsibilities in a complex, ever-evolving, interdisciplinary and often multinational environment. Fortunately, training at the postgraduate level is increasingly being recognized as essential to developing scientific, technical and interpersonal competencies to ultimately enhance the quality of clinical research.

The goal of this program is to prepare trainees for the variety of management and leadership roles in different clinical research settings such as academia, pharmaceutical, medical device or biotech industry, clinical research organizations and regulatory agencies.

Course Organizer and Registration

This course is organized by the CTU Clinical Trial Unit, University Hospital of Basel.
Course details and registration
 

Course Description

The implementation of clinical research projects requires conscientious review of research projects not only in terms of their scientific quality but also in regard to their ethical adequacy and appropriateness. How can we balance the risk-benefit of our projects? Given the importance of ethics for the conduct of drug development and research, it should come as no surprise that many different professional associations, government agencies, and universities have adopted specific codes, rules, and policies relating to research ethics.

Each of these aspects will be carefully considered and discussed in the context of international and national principles and guidelines. These issues need to be carefully adhered to strengthen the health of the clinical trial enterprise to the benefit of patients and the overall health of the public. During our course, representatives from different institutions will introduce and discuss the most important concepts, tools, principles, and methods that can be useful in approaching and resolving ethical dilemmas. Realworld examples and case studies will be introduced and discussed.

Course Program

Day 1
The Evolution of Biomedical Research Ethics / Risk-Benefit Considerations of Research Interventions / Role of Ethics Committees / Successful Submission to an Ethics Committee / Coordinating Human Research in Switzerland / How to Design an Informed Consent / Ethical Review Systems in Europe and European Legislation / Ethics Committees’ Role in Reviewing Safety Information

Day 2
Equipoise / Transparency in Clinical Trials / Common Technical Document / Confidentiality and Intellectual Property / Personal Data Protection / Inducement in Clinical Research – from Recruitment Advertisement to Subject Compensation / Role of Patient Organisations in Clinical Trials (EUPATI) / Public Health Ethics (incl. biobanks)

Day 3
Ethical Aspects of Clinical Research in Children / Informed Consent Process in Pediatric Patients / Clinical Research in Vulnerable Populations / Misconduct and Fraud, Research Integrity / ICH E6 Regulation / Legal and Ethical Framework for Genetic Testing

Learning Outcomes

By the end of the course, students will be able to:

• Name key principles of ethical considerations during clinical research and development
• Discuss ethical concerns for designing, conducting and reporting the results obtained through the conduct of clinical trials
• Understand international and national principles and guidelines which have to be followed when performing clinical trials

Course Faculty

Dr. Jane Barrett
Dr. Julia Bielicki
Dr. Corina Braem
Dr. Thomas Gruberski
Nienke Jones
Dr. Peter Kleist
Dr. Ingrid Klingmann
Dr. Sabine Österle
Dr. Nicole Probst
Magalie Wasem-Tréguer
Dr. Beat Widler

Target Audience

All pharmaceutical and health care professionals who are interested in getting a deeper understanding of ethical and legal aspects in medicines development.

Course Language

English

Course Credits

The course including assessment provides 2 ECTS credits.

Course Date and Venue

Will be announced for November 2022.

Course Fee

Course fee including certificate, electronic course material and coffee breaks is CHF 2000.
A reduced fee applies to participants from academia and nonprofit organizations.

Cancellation Policy

Refund of fee will be given if cancellation is received in written format (ecpm@unibas.ch) before the deadline for registration, after this date no refund can be given.

Deadline for Registration

Will be announced for November 2022.

Course Organizer

This course is organized by the European Center of Pharmaceutical Medicine.

Join courses run by our partner universities in the European University Network, which offer training relevant to drug development sciences and the IMI PharmaTrain syllabus. For an overview of all PharmaTrain Recognized Course Providers please click here.

Course Description

This e-learning course provides an understanding of the key principles and methodological concepts of health economic evaluations. It is based on the well-established face-to-face course on health economics offered by the ECPM. The scientific content was developed by Prof. Thomas Szucs and Prof. Matthias Schwenkglenks as well as other specialists from the field.

Learning Outcomes

At the end of the course, the participants should be able to describe:

• Fundamental concepts of health economics
• Key elements of health economic evaluation
• Assessment and analysis of a published health economic study
• The importance of health economic/pharmacoeconomic methods and concepts for the drug development process, clinical trials, and post-marketing surveillance
• How policymakers set priorities in health care and how health economic evaluations support this process

Structure and Workload

Our e-learning courses provide an interactive environment for self-paced learning. As soon as you have booked the course, the program is accessible online for you during one year at anytime. The course allows you to start/stop at any time. There will be several intermediate tests which will prepare you for the final test. The curriculum consists of nine lessons with a duration of approximately 60 to 90 minutes each. In addition, individual study, such as critical appraisal of specific literature is required (in total: approximately 30 hours). Each lesson is aimed to achieve a set of learning outcomes, using interactive techniques to help reinforce the taught topics.

Course Language

English

Course Credits

After successful completion of the e-learning course, 1 ECTS will be awarded (Certificate of Attendance from the University of Basel).

Course Fee

CHF 650
A reduced fee applies to participants from academia and nonprofit organizations.

Course Organizer

This course is organized by the European Center of Pharmaceutical Medicine.

Course Description

This e-learning course provides an understanding of the safety-related aspects within the drug development process. These range from early preclinical testing, risk/benefit assessment up to clinical adverse event signal detection and monitoring.

Learning Outcomes

At the end of the course, the participants should be able to describe:

• The role of drug safety in the successful development and usage of a medicine to the benefit of patients
• Which safety-related questions need to be answered in early and late drug development
• Tools, techniques, and methodologies used in drug safety evaluation
• What frequent pitfalls related to drug safety considerations occur and why they can lead to discontinuation of drugs in development, label changes or even withdrawal of drugs from the market after launch
• How changes in safety assessment could become part of a new drug development paradigm

Structure and Workload

Our e-learning courses provide an interactive environment for self-paced learning. As soon as you have booked the course, the program is accessible online for you during one year at anytime. The course allows you to start/stop at any time. There will be several intermediate tests which will prepare you for the final test. The curriculum consists of nine lessons with a duration of approximately 60 to 90 minutes each. In addition, individual study, such as critical appraisal of specific literature is required (in total: approximately 30 hours). Each lesson is aimed to achieve a set of learning outcomes, using interactive techniques to help reinforce the taught topics.

Course Language

English

Course Credits

After successful completion of the e-learning course, 1 ECTS will be awarded (Certificate of Attendance from the University of Basel).

Course Fee

CHF 650
A reduced fee applies to participants from academia and nonprofit organizations.

Course Organizer

This course is organized by the European Center of Pharmaceutical Medicine.

Course Description

This e-learning course provides an understanding of the key principles and methodological concepts of personalized drug development. The role of individualized treatment strategies is addressed, including all relevant clinical, ethical and governmental aspects.

Learning Outcomes

At the end of the course, the participants should be able to:

• Understand the biological and clinical concepts of personalized medicine
• Understand the benefits and pitfalls of individualized therapies for patients
• Comprehend the basic elements of predictive and prognostic interventions
• Understand the role of surrogate endpoints and clinically validated biomarkers in personalized medicine
• Understand pharmacogenetic and pharmacogenomic implications
• Be aware of the strategies of R&D processes with personalized drugs
• Understand the economics challenges of personalized medicine and how policymakers set priorities in individualized health care
• Determine legal, regulatory and ethical aspects of personalised medicine

Structure and Workload

Our e-learning courses provide an interactive environment for self-paced learning. As soon as you have booked the course, the program is accessible online for you during one year at anytime. The course allows you to start/stop at any time. There will be several intermediate tests which will prepare you for the final test. The curriculum consists of nine lessons with a duration of approximately 60 to 90 minutes each. In addition individual study, such as critical appraisal of specific literature is required (in total: approximately 30 hours). Each lesson is aimed to achieve a set of learning outcomes, using interactive techniques to help reinforce the taught topics.

Course Language

English

Course Credits

After successful completion of the e-learning course, 1 ECTS will be awarded (Certificate of Attendance from the University of Basel).

Course Fee

CHF 650
A reduced fee applies to participants from academia and nonprofit organizations.

Course Organizer

This course is organized by the European Center of Pharmaceutical Medicine.